Selective serotonin reuptake inhibitors and raft inhibitors shorten the period of Period1-driven circadian bioluminescence rhythms in rat-1 fibroblasts

Life Sciences

Volumn 82, Issue 23-24, 2008, Pages 1169-1174

  Nomura, Kazumi ^a   Castanon Cervantes, Oscar ^a   Davidson, Alec ^a   Fukuhara, Chiaki ^a  

^a Neuroscience Institute   (United States)

Author keywords

Fibroblasts; Lipid raft; Methyl cyclodextrin; Mouse suprachiasmatic nucleus; Real time circadian bioluminescence monitoring; SERT; SSRI; Xylazine

Indexed keywords

CITALOPRAM; FLUOXETINE; FLUVOXAMINE; LIPID; LUCIFERASE; MESSENGER RNA; METHYL BETA CYCLODEXTRIN; PAROXETINE; PER1 PROTEIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLUMINESCENCE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG EFFECT; FIBROBLAST; IN VITRO STUDY; MALE; MONITORING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; SUPRACHIASMATIC NUCLEUS; TRANSGENE; TRANSGENIC MOUSE;

ANIMALS; CIRCADIAN RHYTHM; EYE PROTEINS; FIBROBLASTS; GENES, REPORTER; LUCIFERASES; MALE; MEMBRANE MICRODOMAINS; MICE; MICE, TRANSGENIC; RATS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SUPRACHIASMATIC NUCLEUS; TRANSFECTION;

MUS MUSCULUS; RATTUS;

EID: 43849094992     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.03.024     Document Type: Article

References (39)

1. Balsalobre A., Damiola F., and Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 93 6 (1998) 929-937
2. Benedetti F., Dallaspezia S., Fulgosi M.C., Barbini B., Colombo C., and Smeraldi E. Phase advance is an actmetric correlate of antidepressant response to sleep deprivation and light therapy in bipolar depression. Chronobiology International 24 5 (2007) 921-937
3. Brown S.A., Fleury-Olela F., Nagoshi F., Hauser C., Juge C., Meier C.A., Chicheportiche R., Dayer J.M., Albrecht U., and Schibler U. The period length of fibroblast circadian gene expression varies widely among human individuals. PLoS Biology 3 10 (2005) 1813-1818
4. Chansard M., Molyneux P., Nomura K., Harrington M.E., and Fukuhara C. c-Jun N-terminal kinase inhibitor SP00125 modulates the period of mammalian circadian rhythms. Neuroscience 145 3 (2007) 812-823
5. 2+]i elevation. Toxicology and Applied Pharmacology 218 3 (2007) 265-273
6. Dunlap J.C., Loros J.J., and DeCoursey P.J. Chronobiology: Biological Timekeeping. first ed. (2003), Sinauer Associates, Inc., Sunderland, Massachusetts
7. Ehlers C.L., Frank E., and Kupfer D.J. Social zeitgebers and biological rhythms. A unified approach to understanding the etiology of depression. Archives of General Psychiatry 45 10 (1988) 948-952
8. Fukuhara C., Dirden J.C., and Tosini G. Regulation of period 1 expression in cultured rat pineal. Neurosignals 11 2 (2002) 103-114
9. Fukuhara C., and Tosini G. Peripheral circadian oscillators and their rhythmic regulation. Frontiers in Bioscience 8 (2003) 642-651
10. Gannon R.L., and Millan M.J. Evaluation of serotonin, noradrenaline and dopamine reuptake inhibitors on light-induced phase advances in hamster circadian activity rhythms. Psychopharmacology 195 3 (2007) 325-332
11. Gould T.D., Picchini A.M., Einat H., and Manji H.K. Targeting glycogen synthase kinase-3 in the CNS: implications for the development of new treatments for mood disorders. Current Drug Targets 7 11 (2006) 1399-1409
12. Grandin L.D., Alloy L.B., and Abramson L.Y. The social zeitgeber theory, circadian rhythms, and mood disorders: review and evaluation. Clinical Psychology Review 26 6 (2006) 679-694
13. Harten J.V. Clinical pharmacokinetics of selective serotonin reuptake inhibitors. Clinical Pharmacokinetics 24 3 (1993) 203-220
14. Hasegawa M., and Cahill G.M. Regulation of the circadian oscillator in Xenopus retinal photoreceptors by protein kinases sensitive to the stress-activated protein kinase inhibitor, SB 203580. The Journal of Biological Chemistry 279 21 (2004) 22738-22746
15. Hayashi Y., Sanada K., Hirota T., Shimizu F., and Fukada Y. p38 mitogen-activated protein kinase regulates oscillation of chick pineal circadian clock. The Journal of Biological Chemistry 278 27 (2003) 25166-25171
16. Heninger G.R., Delgado P.L., and Charney D.S. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry 29 1 (1996) 2-11
17. Hirano K., Kimura R., Sugimoto Y., Yamada J., Uchida S., Kato Y., Hashimoto H., and Yamada S. Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors. British Journal of Pharmacology 144 5 (2005) 695-702
18. Hirota T., Okano T., Kokame K., Shirotani-Ikejima H., Miyata T., and Fukuda Y. Glucose down-regulates per1 and per2 mRNA levels and induces circadian gene expression in cultured rat-1 fibroblasts. The Journal of Biological Chemistry 277 46 (2002) 44244-44251
19. Huo H., Guo X., Hong S., Jiang M., Liu X., and Liao K. Lipid rafts/caveolae are essential for insulin-like growth factor-1 receptor signaling during 3T3-L1 preadipocyte differentiation induction. The Journal of Biological Chemistry 278 13 (2003) 11561-11569
20. Izumo M., Johnson C.H., and Yamazaki S. Circadian gene expression in mammalian fibroblasts revealed by real-time luminescence reporting: temperature compensation and damping. Proceedings of the National Academy of Sciences of the United States of America 100 26 (2003) 16089-16094
21. Kaladchibachi S.A., Doble B., Anthopoulos N., Woodgett J.R., and Manoukian A.S. Glycogen synthase kinase 3, circadian rhythms, and bipolar disorder: a molecular link in the therapeutic action of lithium. Journal of Circadian Rhythms 12 (2007) 5:3
22. Klemfuss H. Rhythms and the pharmacology of lithium. Pharmacology & Therapeutics 56 1 (1992) 53-78
23. Ko C.H., and Takahashi J.S. Molecular components of the mammalian circadian clock. Human Molecular Genetics 15 2 (2006) R271-R277
24. Lader M. Limitations of current medical treatments for depression: disturbed circadian rhythms as a possible therapeutic target. European neuropsychopharmacology 17 12 (2007) 743-755
25. Li X., Rosborough K.M., Friedman A.B., Zhu W., and Roth K.A. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. The International Journal of Neuropsychopharmacology 10 1 (2007) 7-19
26. Magnani F., Tate C.G., Wynne S., Williams C., and Haase J. Partitioning of the serotonin transporter into lipid microdomains modulates transport of serotonin. The Journal of Biological Chemistry 279 37 (2004) 38770-38778
27. Malkoff-Schwartz S., Frank E., Anderson B.P., Hlastala S.A., Luther J.F., Sherrill J.T., Houck P.R., and Kupfer D.J. Social rhythm disruption and stressful life events in the onset of bipolar and unipolar episodes. Psychological Medicine 30 5 (2000) 1005-1016
28. McClung C.A. Circadian genes, rhythms and the biology of mood disorder. Pharmacology & Therapeutics 114 2 (2007) 222-232
29. Phiel C.J., and Klein P.S. Molecular targets of lithium action. Annual Review of Pharmacology and Toxicology 41 (2001) 789-813
30. Prosser R.A., Lee H.M., and Wehner A. Serotonergic pre-treatments block in vitro serotonergic phase shifts of the mouse suprachiasmatic nucleus circadian clock. Neuroscience 142 2 (2006) 547-555
31. Scanlon M.S., Williams C.D., and Schloss P. Membrane cholesterol modulates serotonin transporter activity. Biochemistry 40 (2001) 10507-10513
32. Slominski A., Pisarchik A., Zbytek B., Tobin D.J., Kauser S., and Wortsman J. Functional activity of serotoninergic and melatoninergic systems expressed in the skin. Journal of Cellular Physiology 196 1 (2003) 144-153
33. Sokolove P.G., and Bushell W.N. The chi square periodogram: its utility for analysis of circadian rhythms. Journal of Theoretical Biology 72 1 (1978) 131-160
34. Sprouse J., Braselton J., and Reynolds L. Fluoxetine modulates the circadian biological clock via phase advances of suprachiasmatic nucleus neuronal firing. Biological Psychiatry 60 8 (2006) 896-899
35. Ushijima K., Sakaguchi H., Sato Y., To H., Koyanagi S., Higuchi S., and Ohdo S. Chronopharmacological study of antidepressants in forced swimming test of mice. The Journal of Pharmacology and Experimental Therapeutics 315 2 (2005) 764-770
36. Welsh D.K., Yoo S.H., Liu A.C., Takahashi J.S., and Kay S.A. Bioluminescence imaging of individual fibroblasts reveals persistent, independently phased circadian rhythms of clock gene expression. Current Biology 14 24 (2004) 2289-2295
37. Yamazaki S., Numano R., Abe M., Hida A., Takahashi R., Ueda M., Block G.D., Sakaki Y., Menaker M., and Tei H. Resetting central and peripheral circadian oscillators in transgenic rats. Science 288 5466 (2000) 682-685
38. Yin L., Wang J., Klein P.S., and Lazar M.A. Nuclear receptor Rev-erbalpha is a critical lithium-sensitive component of the circadian clock. Science 311 5763 (2006) 1002-1005
39. Yoo S.H., Yamazaki S., Lowrey L.P., Shimomura K., Ko C.H., Buhr E.D., Siepka S.M., Hong H.K., Oh W.J., Yoo O.J., Menaker M., and Takahashi J.S. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proceedings of the National Academy of Sciences of the United States of America 101 15 (2004) 5339-5346